Abbvie executive Patrick Horber appointed as Novartis's President, International Ruchika Sharma6 Sept 2023 12:04 PM ISTBasel: Novartis has announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Novartis concludes acquisition of Chinook Therapeutics Ruchika Sharma13 Aug 2023 12:00 PM ISTBasel: Novartis has announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company...
Patent infringement: Roche sues Novartis unit over generic lung disease drug Ruchika Sharma3 Aug 2023 1:30 PM ISTSwiss drugmaker Roche's Genentech subsidiary has accused a Novartis unit of infringing one of its patents by selling a generic version of its...
Submit Revise Protocol for TIN-816 : CDSCO panel Tells Novartis Dr. Divya Colin18 July 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct the Phase IIa clinical trial of TIN-816 presented by the drug major Novartis, the Subject Expert...
Novartis acquires DTx Pharma for USD 500 million plus milestone payments Ruchika Sharma18 July 2023 12:30 PM ISTThe agreement underscores the Novartis commitment to Neuroscience, one of the company's five core therapeutic areas, and to pursuing innovative...
Novartis to appeal to US Court of Appeals to uphold validity of Entresto combination patent Ruchika Sharma8 July 2023 3:00 PM ISTBasel: Novartis has announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent...
Novartis to divest 'front of eye' ophthalmology assets to Bausch + Lomb for up to 2.5 billion Ruchika Sharma3 July 2023 3:30 PM ISTNovartis will continue to supply Xiidra to patients on behalf of Bausch + Lomb, via transitional agreements for a limited period post-close, to ensure...
Novartis Gets CDSCO panel okay To Study Monoclonal Antibody Ianalumab Dr. Divya Colin17 Jun 2023 6:00 PM ISTNew Delhi: The drug major Novartis has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis to acquire Chinook Therapeutics for up to USD 3.5 billion in boost to late stage pipeline Ruchika Sharma12 Jun 2023 1:00 PM ISTBasel: Novartis said on Monday it agreed to acquire Seattle-based biotech firm Chinook Therapeutics for up to USD 3.5 billion to boost its...
Novartis sees Sandoz adding USD 3 billion in net sales over next five years Ruchika Sharma8 Jun 2023 4:30 PM ISTLondon: Novartis' soon-to-be spun off generics division Sandoz is expected to expand its pipeline and potentially generate an additional $3...
Novartis Kisqali significantly reduced risk of recurrence by 25% across broad population of patients with early breast cancer: Novartis Ruchika Sharma4 Jun 2023 1:00 PM ISTBasel: Novartis has presented positive primary endpoint data from the pivotal Phase III NATALEE trial at the 2023 American Society of Clinical...
